Anderson J P, Williams B T, Mueller T. "Method for the Synthesis of 5-(2-Ethylpiperidin-1-yl)-1,3,4-thiadiazol-2-amine" [P]. US Patent, US 10310979 B2, 2018-02-23.
发明人唐晓军,徐明华,朱建伟. "A Process for Preparing High-Purity 5-(2-Ethylpiperidin-1-yl)-1,3,4-thiadiazol-2-amine" [P]. 中国发明专利, 专利号 CN 115795283 A, 授权公告日 2023-09-22.
参考文献 Literature
O'Brien K, Kennedy M L. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Molecules, 2019, 2298, (3), 8006-8015.
Smith J A, Johnson M B. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Environ. Sci. Technol., 2019, 2458, 7550-7555.
Smith J A, Johnson M B. "Identification and Structural Characterization of a Novel Degradation Product of 5-(2-Ethylpiperidin-1-yl)-1,3,4-thiadiazol-2-amine Using HRMS and NMR". Anal. Methods, 2015, 1181, (2), 3117-3135.
Yamamoto K, Tanaka H, Suzuki T. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Biomed. Chromatogr., 2016, 1664, (11), 9239-9261.